Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cladribine and Pegylated Interferon alpha-2a in Advanced Systemic Mastocytosis
NCT01602939Phase 3Unknown
- Sponsor
- Hospital Virgen de la Salud
- Start
- May 2012
- Primary completion
- Feb 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of cladribine, peginterferon alfa-2a in systemic mastocytosis (SM), sponsored by Hospital Virgen de la Salud. Status: unknown.
02
Drugs
cladribinepeginterferon alfa-2a
03
Conditions
systemic mastocytosis (SM)
Beyond the preview
Go deeper on NCT01602939.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01602939.